Fritextsökning
Innehållstyper
-
AI detects tumor disease – via voice recording
A short voice recording along with facial images – both analyzed with an AI algorithm – can make it possible to detect the rare tumour disease acromegaly and in...
-
BMS and venture capital giant form new company
The American pharmaceutical company Bristol Myers Squibb, together with the venture capital firm Bain Capital, is forming a new biotech company. The company wil...
-
CT technology for when the inside matters
ZEISS METROTOM 1 now at #HandsOnMetrology.
-
ZEISS Lightfield 4D for instant volumetric high-speed imaging
Capturing physiological and neuronal processes in 3D.
-
Moderna utökar samarbete med Open AI – växlar upp med artificiell intelligens
AI-assistenter i alla delar av verksamheten. Det är målet för Moderna, som slutit ett nytt avtal med Open AI. Något som kommer öka kapaciteten kraftigt, enligt ...
-
”AI-teknologin är här – dags för industrin att ta rygg på Läkemedelsverket”
När Läkemedelsverket, som en av de första läkemedelsmyndigheterna i Europa, lanserade sin egen generativa AI-lösning – den lokalt driftade Regulus – sattes ett ...
-
Conference recordings now available
Don't miss out on insights from leading experts.
-
Success for Genmab's antibody-drug conjugate
The Danish company Genmab has received Japanese approval for its treatment for advanced or recurrent cervical cancer.
-
Accelerate your Research with AI-Powered Image Analysis
Comprehensive eBook from ZEISS.
-
600 million SEK for life science - "Should not be the country of moderation"
Sweden will prioritize excellence over breadth in research. This was made clear when the government presented the research proposition for the next four years.
-
ZEISS receives FDA clearance for INTRABEAM 700
With its new treatment platform for intraoperative radiotherapy, ZEISS is actively shaping the medical innovation of neuro tumor therapy.
-
AI upptäcker tumörsjukdom – via röstinspelning
En kort röstinspelning tillsammans med ansiktsbilder – i bägge fallen analyserade med en AI-algoritm – kan göra det möjligt att upptäcka den sällsynta tumörsjuk...
-
AI automates testing of implant coatings
The medical technology group Smith+Nephew uses an AI-supported light microscope ZEISS Axio Imager to inspect coated implants.
-
ZEISS Hosts an exceptional Global Conference on Innovation and Production in Berlin
More than 50 distinguished speakers from leading manufacturing companies.
-
Explore our tailored program for Control 2025
Choose an innovation tour, or join our industry-specific guided tours.
-
Discover the new ZEISS Axioscan 7 clinical
Your digital slide scanner for diagnostics & clinical research.
-
Artificial intelligence in radiology – “Risk prediction is very exciting”
A growing number of solutions based on artificial intelligence are being developed and used in healthcare. According to Sophia Zackrisson, Professor of Radiolog...
-
Så får du ihop ett CV som imponerar på life science-rekryteraren
På dagens arbetsmarknad är det viktigt att alltid ha ett uppdaterat CV och att skriva ett är inte helt enkelt. Men så länge man har ett konkret mål med sin karr...
-
Explore the possibilities of the new ZEISS METROTOM 800 320 kV
Free ZEISS webinar July 10, 9:00-9:45 AM and 5:00-5:45 PM.
-
Advancing Drug Discovery by Combining Complex In-Vitro Models with AI-Powered 3D/4D Image Analysis
Free webinar organized by ZEISS.
-
Studie: Reningsverk en bov i utvecklingen av antibiotikaresistens
hjälp av en AI-modell.
-
The investor: “The major common diseases are hot again”
She has previously been voted Investor of the Year and will now be moderating The Future of Swedish & Danish Life Science congress. We check the temperature of ...
-
Chat GPT gav fel svar och hittade på referenser
Enligt en ny amerikansk studie kan Chat GPT vara farlig att vända sig till med medicinska frågor. Men att den hajpade chattboten hittar på egna fakta förvånar inte läkaren och AI...
-
Quality assurance for research and development of medical devices
Overcome the hurdles of research, development, and QA lab environments within the regulated medical technology industry.